Tag Archives: Laura Sutcliffe

Eli Lilly & Co Gets a Buy Rating from Berenberg Bank

In a report issued on October 24, Laura Sutcliffe from Berenberg Bank assigned a Buy rating to Eli Lilly & Co (NYSE: LLY), with a price target of $98. The company’s shares opened today at $84.16. Sutcliffe has an average

Berenberg Bank Releases a Buy Rating on Gilead Sciences

In a report released yesterday, Laura Sutcliffe from Berenberg Bank assigned a Buy rating to Gilead Sciences (NASDAQ: GILD), with a price target of $96. The company’s shares closed yesterday at $80.01. Sutcliffe has an average return of 11.1% when

Gilead Sciences Receives a Buy from Berenberg Bank

Berenberg Bank analyst Laura Sutcliffe assigned a Buy rating to Gilead Sciences (NASDAQ: GILD) today and set a price target of $86. The company’s shares opened today at $74.29. Sutcliffe has an average return of 5.3% when recommending Gilead Sciences.

Berenberg Bank Assigns a Buy Rating on Eli Lilly & Co

In a report issued on August 3, Laura Sutcliffe from Berenberg Bank assigned a Buy rating to Eli Lilly & Co (NYSE: LLY), with a price target of $98. The company’s shares closed yesterday at $82.31. Sutcliffe has an average

Berenberg Bank Believes Eli Lilly & Co (NYSE: LLY) Won’t Stop Here

Berenberg Bank analyst Laura Sutcliffe assigned a Buy rating to Eli Lilly & Co (NYSE: LLY) on July 25 and set a price target of $100. The company’s shares closed yesterday at $83.02, close to its 52-week high of $86.72.

Berenberg Bank Thinks Gilead Sciences’ Stock is Going to Recover

Gilead Sciences (NASDAQ: GILD) received a Buy rating from Berenberg Bank analyst Laura Sutcliffe today. The company’s shares closed yesterday at $81.70, close to its 52-week low of $76.67. Sutcliffe has an average return of 4.3% when recommending Gilead Sciences.